Literature DB >> 28734872

Modeling the cleavage of von Willebrand factor by ADAMTS13 protease in shear flow.

Brooke Huisman1, Masoud Hoore1, Gerhard Gompper1, Dmitry A Fedosov2.   

Abstract

Von Willebrand factor (VWF) is a key protein in hemostasis as it mediates adhesion of blood platelets to a site of vascular injury. A proper distribution of VWF lengths is important for normal functioning of hemostatic processes, because a diminished number of long VWF chains may significantly limit blood clotting and lead to bleeding, while an abundant number of long VWFs may result in undesired thrombotic events. VWF size distribution is controlled by ADAMTS13 protease, which can cleave VWF chains beyond a critical shear rate when the chains are stretched enough such that cleavage sites become accessible. To better understand the cleavage process, we model VWF cleavage in shear flow using mesoscopic hydrodynamic simulations. Two cleavage models are proposed, a geometrical model based on the degree of local stretching of VWF, and a tension-force model based on instantaneous tension force within VWF bonds. Both models capture the susceptibility of VWF to cleavage at high shear rates; however, the geometrical model appears to be much more robust than the force model. Our simulations show that VWF susceptibility to cleavage in shear flow becomes a universal function of shear rate, independent of VWF length for long enough chains. Furthermore, VWF is cleaved with a higher probability close to its ends in comparison to cleaving in the middle, which results into longer circulation lifetimes of VWF multimers. Simulations of dynamic cleavage of VWF show an exponential distribution of chain lengths, consistently with available in vitro experiments. The proposed cleavage models can be used in realistic simulations of hemostatic processes in blood flow.
Copyright © 2017 IPEM. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cleavage rate; Cleavage susceptibility; Hemostasis; Mesoscopic modeling; Polymer chain in flow; Self-associating chain; Smoothed dissipative particle dynamics

Mesh:

Substances:

Year:  2017        PMID: 28734872     DOI: 10.1016/j.medengphy.2017.06.044

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  6 in total

Review 1.  Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians.

Authors:  Radha Mehta; Muhammad Athar; Sameh Girgis; Atif Hassan; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

2.  Internal Tensile Force and A2 Domain Unfolding of von Willebrand Factor Multimers in Shear Flow.

Authors:  Michael Morabito; Chuqiao Dong; Wei Wei; Xuanhong Cheng; Xiaohui F Zhang; Alparslan Oztekin; Edmund Webb
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

3.  Predicting pathological von Willebrand factor unraveling in elongational flow.

Authors:  Sagar Kania; Alparslan Oztekin; Xuanhong Cheng; X Frank Zhang; Edmund Webb
Journal:  Biophys J       Date:  2021-03-16       Impact factor: 4.033

Review 4.  Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.

Authors:  Diana A Gorog; Robert F Storey; Paul A Gurbel; Udaya S Tantry; Jeffrey S Berger; Mark Y Chan; Daniel Duerschmied; Susan S Smyth; William A E Parker; Ramzi A Ajjan; Gemma Vilahur; Lina Badimon; Jurrien M Ten Berg; Hugo Ten Cate; Flora Peyvandi; Taia T Wang; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2022-01-13       Impact factor: 49.421

Review 5.  The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy.

Authors:  Richard C Becker; A Phillip Owens; Sakthivel Sadayappan
Journal:  Thromb Res       Date:  2020-05-07       Impact factor: 3.944

Review 6.  COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.

Authors:  Richard C Becker; Travis Sexton; Susan Smyth
Journal:  J Thromb Thrombolysis       Date:  2021-08-04       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.